| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antioxidants | 9 | 2024 | 1668 | 2.660 |
Why?
|
| Hydrogen Peroxide | 10 | 2020 | 730 | 2.620 |
Why?
|
| Cardiomegaly | 17 | 2017 | 590 | 2.400 |
Why?
|
| Nanoparticles | 13 | 2024 | 1959 | 2.320 |
Why?
|
| Apoptosis | 28 | 2021 | 9486 | 1.580 |
Why?
|
| Ergocalciferols | 5 | 2014 | 110 | 1.500 |
Why?
|
| Myocardial Reperfusion Injury | 4 | 2021 | 481 | 1.420 |
Why?
|
| Reperfusion Injury | 5 | 2020 | 1023 | 1.410 |
Why?
|
| Benzyl Alcohols | 7 | 2020 | 30 | 1.290 |
Why?
|
| Apoptosis Inducing Factor | 6 | 2011 | 51 | 1.180 |
Why?
|
| Oxidative Stress | 8 | 2024 | 3113 | 1.140 |
Why?
|
| Scavenger Receptors, Class B | 2 | 2024 | 85 | 1.090 |
Why?
|
| Myocytes, Cardiac | 15 | 2019 | 1668 | 1.000 |
Why?
|
| Reactive Oxygen Species | 9 | 2021 | 2141 | 0.990 |
Why?
|
| Oxalic Acid | 2 | 2014 | 20 | 0.930 |
Why?
|
| Polymers | 7 | 2020 | 1617 | 0.920 |
Why?
|
| Receptors, Calcitriol | 2 | 2017 | 360 | 0.840 |
Why?
|
| Caspases | 9 | 2010 | 879 | 0.810 |
Why?
|
| Receptors, LDL | 1 | 2024 | 488 | 0.790 |
Why?
|
| Stilbenes | 2 | 2015 | 155 | 0.780 |
Why?
|
| Cardiovascular Agents | 3 | 2015 | 840 | 0.780 |
Why?
|
| Myocardium | 16 | 2013 | 4726 | 0.730 |
Why?
|
| Cardiotonic Agents | 2 | 2020 | 539 | 0.600 |
Why?
|
| Heart Failure | 13 | 2014 | 11669 | 0.590 |
Why?
|
| Rats, Inbred Dahl | 7 | 2015 | 34 | 0.580 |
Why?
|
| Diltiazem | 2 | 2015 | 131 | 0.560 |
Why?
|
| Prodrugs | 2 | 2015 | 261 | 0.540 |
Why?
|
| Disease Models, Animal | 17 | 2024 | 18252 | 0.530 |
Why?
|
| Rats | 25 | 2021 | 23742 | 0.530 |
Why?
|
| Neovascularization, Physiologic | 7 | 2021 | 1349 | 0.520 |
Why?
|
| Animals | 78 | 2024 | 168459 | 0.500 |
Why?
|
| Mice, Knockout | 10 | 2024 | 14414 | 0.500 |
Why?
|
| Receptor, Endothelin A | 1 | 2015 | 56 | 0.500 |
Why?
|
| Nanotechnology | 2 | 2018 | 714 | 0.480 |
Why?
|
| Steroid Hydroxylases | 1 | 2014 | 93 | 0.470 |
Why?
|
| Hypercalcemia | 1 | 2017 | 423 | 0.470 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2021 | 8181 | 0.460 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2011 | 851 | 0.460 |
Why?
|
| Vitamins | 2 | 2013 | 1635 | 0.450 |
Why?
|
| Cardiac Output, Low | 3 | 2006 | 191 | 0.440 |
Why?
|
| Cardiovascular Diseases | 9 | 2019 | 15500 | 0.440 |
Why?
|
| Pyrrolidines | 1 | 2015 | 338 | 0.430 |
Why?
|
| Signal Transduction | 19 | 2021 | 23445 | 0.420 |
Why?
|
| Heart | 12 | 2011 | 4404 | 0.400 |
Why?
|
| Myocardial Infarction | 7 | 2021 | 11460 | 0.390 |
Why?
|
| Phosphates | 1 | 2015 | 770 | 0.380 |
Why?
|
| Boronic Acids | 1 | 2015 | 915 | 0.380 |
Why?
|
| Mitochondrial Proteins | 3 | 2007 | 976 | 0.380 |
Why?
|
| Blood Pressure | 7 | 2016 | 8481 | 0.370 |
Why?
|
| Hypertension | 7 | 2017 | 8540 | 0.360 |
Why?
|
| Atrial Natriuretic Factor | 6 | 2015 | 350 | 0.350 |
Why?
|
| Nanostructures | 1 | 2015 | 553 | 0.350 |
Why?
|
| Vascular Endothelial Growth Factor A | 8 | 2021 | 3492 | 0.350 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2010 | 173 | 0.330 |
Why?
|
| Protein Kinase C | 2 | 2009 | 1202 | 0.320 |
Why?
|
| Mice | 39 | 2024 | 81525 | 0.320 |
Why?
|
| Dystrophin | 1 | 2010 | 283 | 0.320 |
Why?
|
| Serpins | 1 | 2010 | 247 | 0.320 |
Why?
|
| Disease Progression | 2 | 2024 | 13506 | 0.320 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2011 | 397 | 0.310 |
Why?
|
| Vitamin D | 2 | 2014 | 3303 | 0.310 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2016 | 613 | 0.310 |
Why?
|
| Gene Expression Regulation | 13 | 2016 | 11903 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2014 | 2455 | 0.300 |
Why?
|
| Oxalates | 2 | 2020 | 98 | 0.300 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2010 | 267 | 0.290 |
Why?
|
| Calcium | 3 | 2017 | 5722 | 0.280 |
Why?
|
| Angiotensin II | 4 | 2017 | 849 | 0.270 |
Why?
|
| Ischemia | 4 | 2021 | 1882 | 0.270 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2009 | 2865 | 0.260 |
Why?
|
| Muscle Cells | 1 | 2006 | 195 | 0.250 |
Why?
|
| Mannose-Binding Lectins | 1 | 2005 | 96 | 0.250 |
Why?
|
| Peroneal Neuropathies | 1 | 2005 | 22 | 0.250 |
Why?
|
| Coronary Artery Disease | 2 | 2024 | 6403 | 0.250 |
Why?
|
| Muscular Dystrophies | 1 | 2007 | 390 | 0.250 |
Why?
|
| Peroneal Nerve | 1 | 2005 | 76 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 12 | 2024 | 22169 | 0.250 |
Why?
|
| Cell Fusion | 1 | 2005 | 294 | 0.240 |
Why?
|
| Diet, Atherogenic | 1 | 2024 | 92 | 0.240 |
Why?
|
| Caspase 3 | 3 | 2016 | 731 | 0.240 |
Why?
|
| Sodium Chloride | 1 | 2007 | 587 | 0.240 |
Why?
|
| RNA, Messenger | 10 | 2016 | 12795 | 0.240 |
Why?
|
| Mitochondria, Heart | 4 | 2010 | 229 | 0.230 |
Why?
|
| Phagosomes | 1 | 2005 | 199 | 0.230 |
Why?
|
| Sensation Disorders | 1 | 2005 | 160 | 0.230 |
Why?
|
| Gene Expression | 6 | 2016 | 7581 | 0.230 |
Why?
|
| Endonucleases | 1 | 2007 | 371 | 0.230 |
Why?
|
| Sodium, Dietary | 1 | 2007 | 425 | 0.230 |
Why?
|
| Hindlimb | 2 | 2017 | 513 | 0.220 |
Why?
|
| Muscle, Skeletal | 5 | 2017 | 4948 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2016 | 4352 | 0.210 |
Why?
|
| Viral Proteins | 1 | 2010 | 1804 | 0.210 |
Why?
|
| Arthrogryposis | 1 | 2003 | 68 | 0.210 |
Why?
|
| Skin Temperature | 1 | 2003 | 96 | 0.210 |
Why?
|
| Nitric Oxide Synthase Type III | 5 | 2017 | 705 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2016 | 558 | 0.210 |
Why?
|
| Mitochondria | 4 | 2011 | 3624 | 0.200 |
Why?
|
| Cell Nucleus | 2 | 2011 | 2909 | 0.200 |
Why?
|
| Proteins | 3 | 2007 | 6032 | 0.200 |
Why?
|
| Chemokine CCL2 | 2 | 2016 | 605 | 0.200 |
Why?
|
| Heart Diseases | 3 | 2015 | 2781 | 0.200 |
Why?
|
| Immunoblotting | 3 | 2016 | 1646 | 0.200 |
Why?
|
| Ion Channels | 1 | 2007 | 1040 | 0.200 |
Why?
|
| Lectins, C-Type | 1 | 2005 | 585 | 0.200 |
Why?
|
| Renin-Angiotensin System | 3 | 1996 | 737 | 0.200 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 1964 | 0.200 |
Why?
|
| Aortic Valve Stenosis | 1 | 2014 | 2001 | 0.200 |
Why?
|
| Polyneuropathies | 1 | 2003 | 137 | 0.200 |
Why?
|
| Cell Hypoxia | 2 | 2004 | 656 | 0.200 |
Why?
|
| Serine Endopeptidases | 1 | 2007 | 1022 | 0.190 |
Why?
|
| Male | 37 | 2024 | 360804 | 0.190 |
Why?
|
| Hypertrophy | 3 | 2015 | 561 | 0.180 |
Why?
|
| Vitamin D Deficiency | 1 | 2010 | 1388 | 0.170 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2014 | 276 | 0.170 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2015 | 1809 | 0.170 |
Why?
|
| Enzyme Activation | 5 | 2011 | 3597 | 0.170 |
Why?
|
| Antihypertensive Agents | 1 | 2009 | 2024 | 0.170 |
Why?
|
| Phagocytosis | 1 | 2005 | 1528 | 0.170 |
Why?
|
| Bilirubin | 1 | 2021 | 436 | 0.170 |
Why?
|
| Peripheral Nerves | 1 | 2003 | 479 | 0.170 |
Why?
|
| Hemodynamics | 6 | 2020 | 4159 | 0.160 |
Why?
|
| Neuropeptide Y | 1 | 2020 | 192 | 0.160 |
Why?
|
| Foot | 1 | 2003 | 575 | 0.160 |
Why?
|
| RNA | 3 | 2005 | 2726 | 0.160 |
Why?
|
| Lipopolysaccharides | 2 | 2006 | 2206 | 0.160 |
Why?
|
| Cells, Cultured | 9 | 2015 | 18965 | 0.160 |
Why?
|
| Gene Expression Profiling | 5 | 2011 | 9420 | 0.150 |
Why?
|
| Mice, Transgenic | 12 | 2017 | 9539 | 0.150 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 1886 | 0.150 |
Why?
|
| Endothelial Cells | 5 | 2017 | 3548 | 0.150 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 387 | 0.150 |
Why?
|
| Peptide Fragments | 2 | 2021 | 5112 | 0.150 |
Why?
|
| Cell Death | 3 | 2019 | 1678 | 0.150 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2017 | 58 | 0.150 |
Why?
|
| Fibrosis | 3 | 2014 | 2049 | 0.150 |
Why?
|
| Rats, Inbred SHR | 1 | 2017 | 186 | 0.140 |
Why?
|
| Solitary Nucleus | 1 | 2017 | 54 | 0.140 |
Why?
|
| Random Allocation | 2 | 2020 | 2395 | 0.140 |
Why?
|
| GATA4 Transcription Factor | 2 | 2009 | 124 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4575 | 0.140 |
Why?
|
| Leydig Cells | 1 | 2016 | 55 | 0.140 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2016 | 28 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2017 | 546 | 0.130 |
Why?
|
| Amino Acid Chloromethyl Ketones | 2 | 2010 | 68 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2822 | 0.130 |
Why?
|
| Adrenal Cortex | 1 | 2016 | 134 | 0.130 |
Why?
|
| Microscopy, Confocal | 4 | 2015 | 1971 | 0.130 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2016 | 118 | 0.130 |
Why?
|
| Boron | 1 | 2015 | 37 | 0.130 |
Why?
|
| Reactive Nitrogen Species | 1 | 2015 | 34 | 0.130 |
Why?
|
| Cell Line | 3 | 2015 | 15601 | 0.130 |
Why?
|
| Doxorubicin | 2 | 2014 | 2224 | 0.130 |
Why?
|
| Polypropylenes | 1 | 2015 | 63 | 0.130 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2011 | 1723 | 0.120 |
Why?
|
| Biological Clocks | 1 | 2017 | 318 | 0.120 |
Why?
|
| Calcium Channel Blockers | 2 | 2015 | 694 | 0.120 |
Why?
|
| Ventricular Function, Left | 6 | 2021 | 3879 | 0.120 |
Why?
|
| Silicon | 1 | 2015 | 142 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 4 | 2014 | 1486 | 0.120 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2014 | 41 | 0.120 |
Why?
|
| Sulfides | 1 | 2015 | 169 | 0.120 |
Why?
|
| Lymphocytosis | 1 | 1995 | 121 | 0.120 |
Why?
|
| Esters | 1 | 2015 | 211 | 0.120 |
Why?
|
| Myocardial Contraction | 4 | 2020 | 1515 | 0.120 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2005 | 1914 | 0.120 |
Why?
|
| Phenylephrine | 1 | 2015 | 293 | 0.120 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2016 | 165 | 0.120 |
Why?
|
| Superoxides | 1 | 2015 | 387 | 0.120 |
Why?
|
| Myocardial Ischemia | 2 | 2020 | 2113 | 0.110 |
Why?
|
| Agammaglobulinemia | 1 | 1995 | 171 | 0.110 |
Why?
|
| Proline | 1 | 2015 | 457 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 3 | 1996 | 1039 | 0.110 |
Why?
|
| Echocardiography | 4 | 2015 | 4989 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1996 | 586 | 0.110 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 1496 | 0.110 |
Why?
|
| Dioxanes | 1 | 2013 | 36 | 0.110 |
Why?
|
| Genes, Reporter | 1 | 2017 | 1529 | 0.110 |
Why?
|
| Benzaldehydes | 1 | 2013 | 59 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 1386 | 0.100 |
Why?
|
| Collagen Type III | 1 | 2013 | 91 | 0.100 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2014 | 177 | 0.100 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 678 | 0.100 |
Why?
|
| Aldosterone | 1 | 2017 | 870 | 0.100 |
Why?
|
| Hydrogen Sulfide | 1 | 2013 | 141 | 0.100 |
Why?
|
| Lupus Nephritis | 1 | 2016 | 316 | 0.100 |
Why?
|
| Capillaries | 1 | 2016 | 755 | 0.100 |
Why?
|
| Selenium | 1 | 2015 | 417 | 0.100 |
Why?
|
| Hypertension, Portal | 1 | 2014 | 226 | 0.100 |
Why?
|
| Mosaicism | 1 | 2016 | 475 | 0.100 |
Why?
|
| Inflammation | 5 | 2021 | 10773 | 0.100 |
Why?
|
| Steroids | 1 | 2017 | 929 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1334 | 0.100 |
Why?
|
| Sodium | 1 | 2017 | 1588 | 0.100 |
Why?
|
| Ovary | 1 | 2016 | 959 | 0.100 |
Why?
|
| Nanomedicine | 1 | 2015 | 290 | 0.100 |
Why?
|
| Macrophages | 2 | 2013 | 5769 | 0.100 |
Why?
|
| von Willebrand Factor | 1 | 2016 | 673 | 0.100 |
Why?
|
| Capillary Permeability | 1 | 1995 | 773 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5671 | 0.100 |
Why?
|
| Humans | 37 | 2019 | 761504 | 0.100 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 934 | 0.100 |
Why?
|
| Blood Vessels | 1 | 2017 | 1113 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 3 | 2015 | 6216 | 0.100 |
Why?
|
| Isoenzymes | 1 | 1996 | 1687 | 0.100 |
Why?
|
| Heart Ventricles | 2 | 2002 | 3807 | 0.090 |
Why?
|
| Female | 21 | 2024 | 392644 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2014 | 473 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2015 | 1880 | 0.090 |
Why?
|
| Neuropeptides | 1 | 2017 | 944 | 0.090 |
Why?
|
| Polyesters | 1 | 2013 | 373 | 0.090 |
Why?
|
| Protein Kinase C-alpha | 1 | 2011 | 113 | 0.090 |
Why?
|
| Naphthalimides | 1 | 2010 | 22 | 0.090 |
Why?
|
| 1-Naphthylamine | 1 | 2010 | 49 | 0.090 |
Why?
|
| Proteinuria | 1 | 2013 | 607 | 0.090 |
Why?
|
| Cell Size | 3 | 2009 | 624 | 0.090 |
Why?
|
| Parathyroid Hormone | 1 | 2017 | 1803 | 0.090 |
Why?
|
| Cardiovirus Infections | 1 | 2010 | 20 | 0.090 |
Why?
|
| Particle Size | 1 | 2015 | 1648 | 0.090 |
Why?
|
| Rats, Wistar | 2 | 2009 | 1848 | 0.090 |
Why?
|
| Pregnancy Proteins | 2 | 2008 | 222 | 0.090 |
Why?
|
| Liver | 2 | 2016 | 7529 | 0.090 |
Why?
|
| Aorta | 2 | 2016 | 2042 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2016 | 695 | 0.080 |
Why?
|
| Hypercholesterolemia | 1 | 2016 | 1141 | 0.080 |
Why?
|
| Collagen Type I | 1 | 2013 | 616 | 0.080 |
Why?
|
| Oxygen | 1 | 2001 | 4227 | 0.080 |
Why?
|
| Electromyography | 2 | 2005 | 1394 | 0.080 |
Why?
|
| Metoprolol | 1 | 2009 | 90 | 0.080 |
Why?
|
| Aging | 2 | 2005 | 8708 | 0.080 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2009 | 103 | 0.080 |
Why?
|
| Vidarabine | 1 | 2010 | 336 | 0.080 |
Why?
|
| Antibodies, Neoplasm | 1 | 2010 | 281 | 0.080 |
Why?
|
| Caspase 9 | 2 | 2006 | 185 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 878 | 0.080 |
Why?
|
| Nitroglycerin | 1 | 2009 | 329 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2010 | 321 | 0.080 |
Why?
|
| Pentosyltransferases | 1 | 2007 | 62 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1118 | 0.070 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2007 | 62 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2017 | 2047 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2008 | 223 | 0.070 |
Why?
|
| Quinolones | 1 | 2010 | 378 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2014 | 1403 | 0.070 |
Why?
|
| DNA | 2 | 2001 | 7212 | 0.070 |
Why?
|
| Recombinant Proteins | 4 | 2006 | 6534 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 1616 | 0.070 |
Why?
|
| Animal Feed | 1 | 2007 | 112 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2009 | 1642 | 0.070 |
Why?
|
| Pre-Eclampsia | 1 | 2016 | 1231 | 0.070 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2017 | 260 | 0.070 |
Why?
|
| Organ Size | 3 | 2007 | 2254 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 477 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2004 | 1545 | 0.060 |
Why?
|
| Receptors, Mitogen | 1 | 2005 | 61 | 0.060 |
Why?
|
| Electrophoresis | 1 | 2005 | 227 | 0.060 |
Why?
|
| Ventricular Pressure | 1 | 2006 | 210 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 1405 | 0.060 |
Why?
|
| Cattle | 2 | 2009 | 3849 | 0.060 |
Why?
|
| Spectrophotometry | 1 | 2005 | 309 | 0.060 |
Why?
|
| Phosphorylation | 4 | 2016 | 8320 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2009 | 943 | 0.060 |
Why?
|
| Protein Transport | 1 | 2011 | 1967 | 0.060 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2006 | 379 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2057 | 0.060 |
Why?
|
| DNA Primers | 2 | 2009 | 2819 | 0.060 |
Why?
|
| Troponin I | 1 | 2009 | 651 | 0.060 |
Why?
|
| Pleural Cavity | 1 | 2004 | 25 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 4234 | 0.060 |
Why?
|
| Adenoviridae | 4 | 2017 | 1084 | 0.060 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 2218 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2014 | 1935 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2010 | 2665 | 0.060 |
Why?
|
| Cytochrome c Group | 2 | 2002 | 122 | 0.060 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2010 | 819 | 0.060 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 809 | 0.060 |
Why?
|
| North America | 1 | 2007 | 1276 | 0.060 |
Why?
|
| Congresses as Topic | 1 | 2009 | 803 | 0.060 |
Why?
|
| Neural Conduction | 1 | 2005 | 441 | 0.060 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2006 | 629 | 0.060 |
Why?
|
| Coronary Restenosis | 1 | 2006 | 396 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2019 | 3429 | 0.060 |
Why?
|
| Actinin | 2 | 2002 | 163 | 0.060 |
Why?
|
| COS Cells | 1 | 2005 | 1130 | 0.060 |
Why?
|
| Thermometers | 1 | 2003 | 42 | 0.050 |
Why?
|
| Sepsis | 2 | 2008 | 2585 | 0.050 |
Why?
|
| Radiculopathy | 1 | 2005 | 202 | 0.050 |
Why?
|
| Neurons, Afferent | 1 | 2005 | 498 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2013 | 2979 | 0.050 |
Why?
|
| Myocarditis | 1 | 2010 | 788 | 0.050 |
Why?
|
| Muscle Weakness | 1 | 2005 | 412 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2005 | 542 | 0.050 |
Why?
|
| Connexin 43 | 1 | 2003 | 200 | 0.050 |
Why?
|
| Receptor, Insulin | 1 | 2006 | 835 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 701 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2008 | 829 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 4615 | 0.050 |
Why?
|
| Sirolimus | 2 | 2006 | 1533 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2011 | 2135 | 0.050 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2004 | 353 | 0.050 |
Why?
|
| Exercise Therapy | 1 | 2008 | 929 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2004 | 3778 | 0.050 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2004 | 293 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2016 | 4398 | 0.050 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 4806 | 0.050 |
Why?
|
| Cadaver | 1 | 2005 | 1358 | 0.050 |
Why?
|
| Physical Conditioning, Animal | 1 | 2004 | 365 | 0.050 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2001 | 110 | 0.050 |
Why?
|
| Viral Load | 1 | 2010 | 3332 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 2243 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 3792 | 0.050 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2006 | 499 | 0.050 |
Why?
|
| Aerobiosis | 1 | 2000 | 100 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 585 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2014 | 234 | 0.040 |
Why?
|
| Genes, bcl-2 | 1 | 2000 | 119 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2003 | 1262 | 0.040 |
Why?
|
| Sarcomeres | 1 | 2003 | 368 | 0.040 |
Why?
|
| Growth | 1 | 2002 | 365 | 0.040 |
Why?
|
| Leg | 1 | 2005 | 1088 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2005 | 870 | 0.040 |
Why?
|
| Lysosomes | 1 | 2005 | 924 | 0.040 |
Why?
|
| Models, Cardiovascular | 2 | 2003 | 981 | 0.040 |
Why?
|
| Autophagy | 1 | 2008 | 1326 | 0.040 |
Why?
|
| Reoperation | 1 | 2010 | 4303 | 0.040 |
Why?
|
| Pleural Neoplasms | 1 | 2004 | 609 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 237 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 10766 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2017 | 3734 | 0.040 |
Why?
|
| Posture | 1 | 2003 | 957 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2014 | 4320 | 0.040 |
Why?
|
| Enzyme Induction | 2 | 2014 | 452 | 0.040 |
Why?
|
| Mesothelioma | 1 | 2004 | 807 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2011 | 5972 | 0.040 |
Why?
|
| Neurons | 1 | 2017 | 9463 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2005 | 1626 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2007 | 1797 | 0.040 |
Why?
|
| Bibenzyls | 1 | 2017 | 11 | 0.040 |
Why?
|
| Phenotype | 4 | 2016 | 16591 | 0.040 |
Why?
|
| Blotting, Western | 4 | 2010 | 5035 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2001 | 655 | 0.040 |
Why?
|
| Mutation | 4 | 2016 | 30052 | 0.040 |
Why?
|
| Receptors, Angiotensin | 2 | 1994 | 141 | 0.040 |
Why?
|
| Reticulocytosis | 1 | 2016 | 10 | 0.040 |
Why?
|
| Models, Biological | 2 | 2017 | 9469 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 3712 | 0.040 |
Why?
|
| Heart Rate | 1 | 2009 | 4195 | 0.040 |
Why?
|
| Cell Survival | 1 | 2007 | 5791 | 0.040 |
Why?
|
| Septal Nuclei | 1 | 2017 | 85 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1246 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2004 | 2915 | 0.030 |
Why?
|
| Anemia, Macrocytic | 1 | 2016 | 53 | 0.030 |
Why?
|
| Protein Kinase C-epsilon | 1 | 1996 | 43 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2014 | 1967 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2016 | 53 | 0.030 |
Why?
|
| Receptors, Lipoprotein | 1 | 2016 | 88 | 0.030 |
Why?
|
| Transfection | 2 | 2004 | 5774 | 0.030 |
Why?
|
| Time Factors | 4 | 2013 | 39967 | 0.030 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2016 | 71 | 0.030 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 11076 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2016 | 189 | 0.030 |
Why?
|
| Walking | 1 | 2003 | 1198 | 0.030 |
Why?
|
| Pregnancy, Animal | 1 | 2016 | 124 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 2898 | 0.030 |
Why?
|
| Angiotensins | 1 | 2016 | 143 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2006 | 2645 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2003 | 1779 | 0.030 |
Why?
|
| Child | 3 | 2010 | 80153 | 0.030 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2017 | 278 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2016 | 421 | 0.030 |
Why?
|
| Verapamil | 1 | 1995 | 242 | 0.030 |
Why?
|
| Stents | 1 | 2006 | 3179 | 0.030 |
Why?
|
| Models, Animal | 3 | 2008 | 2112 | 0.030 |
Why?
|
| Depression, Chemical | 1 | 1994 | 184 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2014 | 151 | 0.030 |
Why?
|
| Antigen-Antibody Complex | 1 | 2016 | 510 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2005 | 26198 | 0.030 |
Why?
|
| Solubility | 1 | 2016 | 1091 | 0.030 |
Why?
|
| Yolk Sac | 1 | 2014 | 79 | 0.030 |
Why?
|
| Adult | 5 | 2007 | 221177 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 670 | 0.030 |
Why?
|
| Blood Circulation | 1 | 2015 | 248 | 0.030 |
Why?
|
| Elasticity | 1 | 2016 | 655 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2017 | 664 | 0.030 |
Why?
|
| Motor Activity | 1 | 2004 | 2715 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 2645 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2007 | 42230 | 0.030 |
Why?
|
| Insulin | 2 | 2006 | 6596 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 2416 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 2872 | 0.030 |
Why?
|
| Coronary Occlusion | 1 | 2016 | 304 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9177 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 855 | 0.030 |
Why?
|
| Microvessels | 1 | 2017 | 577 | 0.030 |
Why?
|
| Systole | 2 | 2006 | 936 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2009 | 3816 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2017 | 826 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 366 | 0.030 |
Why?
|
| Infant | 2 | 2005 | 36192 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 676 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2006 | 3963 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 4431 | 0.020 |
Why?
|
| Cell Proliferation | 3 | 2017 | 10445 | 0.020 |
Why?
|
| Biological Transport | 1 | 1996 | 2091 | 0.020 |
Why?
|
| Pressure | 2 | 2008 | 1154 | 0.020 |
Why?
|
| Sex Factors | 1 | 2005 | 10552 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2469 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 2013 | 568 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 629 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 3615 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 1444 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 3429 | 0.020 |
Why?
|
| Eating | 1 | 2017 | 1539 | 0.020 |
Why?
|
| Encephalomyocarditis virus | 1 | 2010 | 21 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 58976 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 7594 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 12974 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2510 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 4511 | 0.020 |
Why?
|
| Vasodilation | 1 | 2013 | 962 | 0.020 |
Why?
|
| Podocytes | 1 | 2013 | 405 | 0.020 |
Why?
|
| Ligands | 1 | 2016 | 3272 | 0.020 |
Why?
|
| Syndrome | 1 | 1995 | 3267 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2008 | 6228 | 0.020 |
Why?
|
| Age Factors | 1 | 2005 | 18395 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 39106 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 2014 | 735 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 1181 | 0.020 |
Why?
|
| LEOPARD Syndrome | 1 | 2008 | 12 | 0.020 |
Why?
|
| Adolescent | 2 | 2007 | 88319 | 0.020 |
Why?
|
| Calmodulin | 1 | 2009 | 218 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 64680 | 0.020 |
Why?
|
| Aged | 3 | 2005 | 169289 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1902 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1994 | 1516 | 0.020 |
Why?
|
| Noonan Syndrome | 1 | 2008 | 120 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6075 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 1927 | 0.020 |
Why?
|
| Placenta | 1 | 2016 | 1709 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2009 | 343 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2009 | 472 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2017 | 3058 | 0.020 |
Why?
|
| Homeostasis | 2 | 2014 | 3323 | 0.020 |
Why?
|
| Rats, Zucker | 1 | 2006 | 131 | 0.020 |
Why?
|
| Cecum | 1 | 2006 | 233 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2005 | 80636 | 0.020 |
Why?
|
| Base Sequence | 2 | 2009 | 12441 | 0.020 |
Why?
|
| Swine | 2 | 2006 | 5915 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5869 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2006 | 428 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 2006 | 3395 | 0.020 |
Why?
|
| Endotoxemia | 1 | 2006 | 196 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2007 | 41487 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 2006 | 437 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 1900 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2013 | 4124 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 2009 | 871 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 5789 | 0.010 |
Why?
|
| Androstadienes | 1 | 2006 | 348 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 4544 | 0.010 |
Why?
|
| Diastole | 1 | 2006 | 782 | 0.010 |
Why?
|
| Postmortem Changes | 1 | 2004 | 119 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 615 | 0.010 |
Why?
|
| Middle Aged | 3 | 2005 | 220895 | 0.010 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2004 | 197 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 12128 | 0.010 |
Why?
|
| Lymphatic System | 1 | 2004 | 254 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2006 | 903 | 0.010 |
Why?
|
| Injections | 1 | 2006 | 830 | 0.010 |
Why?
|
| Flavonoids | 1 | 2006 | 445 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2002 | 223 | 0.010 |
Why?
|
| Thrombosis | 1 | 2016 | 2942 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2002 | 73 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2016 | 5914 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2009 | 2919 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3810 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2004 | 672 | 0.010 |
Why?
|
| Cell-Free System | 1 | 2002 | 340 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2002 | 190 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 20098 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2477 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 532 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2001 | 184 | 0.010 |
Why?
|
| Physical Exertion | 1 | 2003 | 667 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2001 | 311 | 0.010 |
Why?
|
| Kidney | 1 | 2016 | 7048 | 0.010 |
Why?
|
| Collagen | 1 | 2009 | 2638 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 1749 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 1991 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2001 | 283 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2003 | 434 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2009 | 2490 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 13380 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 441 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2000 | 203 | 0.010 |
Why?
|
| Gene Library | 1 | 2002 | 1059 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2006 | 1725 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2004 | 1135 | 0.010 |
Why?
|
| Cytosol | 1 | 2002 | 888 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 2000 | 405 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 2561 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 2269 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2000 | 852 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 1301 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 2113 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2006 | 4471 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2006 | 3096 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 29874 | 0.010 |
Why?
|
| Saralasin | 1 | 1993 | 34 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 4465 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2004 | 3466 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2001 | 2932 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 13446 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2000 | 1974 | 0.010 |
Why?
|
| Losartan | 1 | 1993 | 265 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 3448 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14666 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 17635 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2004 | 4936 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2003 | 6377 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 9351 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 5671 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 3612 | 0.000 |
Why?
|
| Biphenyl Compounds | 1 | 1993 | 1007 | 0.000 |
Why?
|
| Tetrazoles | 1 | 1993 | 909 | 0.000 |
Why?
|
| Imidazoles | 1 | 1993 | 1180 | 0.000 |
Why?
|
| Prognosis | 1 | 2004 | 29625 | 0.000 |
Why?
|